Fundación Jiménez Díaz -ko ikertzaileekin lankidetzan egindako argitalpenak (31)

2022

  1. Consensus on the Definition of Control and Remission in Chronic Urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 4, pp. 261-269

2019

  1. Psychometric properties of the Spanish version of the once-daily Urticaria Activity Score (UAS) in patients with chronic spontaneous urticaria managed in clinical practice (the EVALUAS study)

    Health and Quality of Life Outcomes, Vol. 17, Núm. 1

  2. Therapeutic strategy according to differences in response to omalizumab in patients with chronic spontaneous urticaria giménez

    Journal of Investigational Allergology and Clinical Immunology, Vol. 29, Núm. 5, pp. 338-348

2017

  1. Allergic rhinitis severity can be assessed using a visual analogue scale in mild, moderate and severe

    Rhinology, Vol. 55, Núm. 1, pp. 34-38

  2. Allergy rhinitis: Similarities and differences between children and adults

    Rhinology, Vol. 55, Núm. 4, pp. 326-331

  3. Heterogeneity in allergy to mollusks: A clinical-immunological study in a population from the north of Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 27, Núm. 4, pp. 252-260

  4. Management of chronic spontaneous urticaria in routine clinical practice: A Delphi-method questionnaire among specialists to test agreement with current European guidelines statements

    Allergologia et Immunopathologia, Vol. 45, Núm. 2, pp. 134-144

2016

  1. Allergic rhinitis causes loss of smell in children: The OLFAPEDRIAL study

    Pediatric Allergy and Immunology, Vol. 27, Núm. 8, pp. 867-870

2015

  1. Management of urticaria: Not too complicated, not too simple

    Clinical and Experimental Allergy, Vol. 45, Núm. 4, pp. 731-743

2014

  1. Assessment of severity and quality of life in chronic urticaria

    Journal of Investigational Allergology and Clinical Immunology, Vol. 24, Núm. 2, pp. 80-86

2013

  1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

    Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684

  2. Bilastine for the treatment of urticaria

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544

  3. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

    Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

  4. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice

    Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228

2012

  1. Development of poly(anhydride) nanoparticles loaded with peanut proteins: The influence of preparation method on the immunogenic properties

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 82, Núm. 2, pp. 241-249

  2. Validation of the modified allergic rhinitis and its impact on asthma (ARIA) severity classification in allergic rhinitis children: The PEDRIAL study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 67, Núm. 11, pp. 1437-1442

2011

  1. Validation of ARIA (Allergic Rhinitis and its Impact on Asthma) classification in a pediatric population: The PEDRIAL study

    Pediatric Allergy and Immunology, Vol. 22, Núm. 4, pp. 388-392

2010

  1. Validation of ARIA duration and severity classifications in Spanish allergic rhinitis patients - The ADRIAL cohort Study

    Rhinology, Vol. 48, Núm. 2, pp. 201-205

2009

  1. Allergic conjunctivitis and H1 antihistamines

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 11-18

  2. Allergic rhinitis and school performance

    Journal of Investigational Allergology and Clinical Immunology, Vol. 19, Núm. SUPPL. 1, pp. 32-39